ity columns of ORF15 fusion proteins, only ORF11 and ORF14 proteins were purified, free of the fusion partner, to homogeneity. Conclusion: All of the six targeted RD1 genes were amplified and five expressed using E. coli hosts, but only two of the expressed proteins were purified to homogeneity. Alternative expression systems are required to obtain all RD1 proteins for functional characterization.
Introduction
Tuberculosis (TB) is a major infectious disease problem around the world with an estimated incidence of 8.9 million cases and 1.7 million deaths annually [1] . The global problem of TB is worsening mainly due to the increase in multidrug-resistant TB and coinfection with HIV [1] . The effective control of TB requires identification and availability of Mycobacterium tuberculosis -specific proteins as immunological reagents for diagnosis of TB. Although a large number of proteins of M. tuberculosis have been identified in the past, most of them are shared with the vaccine strains of Mycobacterium bovis BCG [2] [3] [4] [5] , and thus differentiation between individuals infected with M. tuberculosis and vaccinated with M. bo-vis BCG is not possible. The availability of purified M. tuberculosis -specific proteins is also required to delineate the mechanisms of virulence, identify targets for new and pathogen-specific drugs and develop subunit vaccines against TB [6, 7] .
Comparisons of mycobacterial genome sequences have led to the identification of several regions of differences (RD) that are conserved in M. tuberculosis but absent in M. bovis BCG [8] [9] [10] . Among these regions, RD1 (a 9.5-kb DNA segment) is of special interest because it is present in all virulent laboratory and clinical strains/isolates of pathogenic M. tuberculosis but deleted in all vaccine strains of M. bovis BCG [8] [9] [10] . The reintroduction of RD1 into M. bovis BCG resulted in a protein expression profile almost identical to that of virulent M. tuberculosis [8] . The immunological and pathological importance of proteins encoded by RD1 was predicted in studies in which two major M. tuberculosis -specific antigenic proteins, i.e. ESAT6 and CFP10, were found encoded by genes present in RD1 [11, 12] , and deletion of RD1 region from M. tuberculosis decreased its capacity to cause disease in an experimental animal model of TB [13] .
A careful bioinformatics analysis of the RD1 sequence has revealed the presence of 14 open reading frames (ORF2 to ORF15) deleted in M. bovis BCG [14] . These ORFs were predicted to vary between 0.3 and 2.2 kb in size, and 13 were expressed at the mRNA level [15] . However, to study the functional relevance of these ORFs, it was essential to obtain the encoded proteins in purified form. A number of previous studies have shown that mycobacterial proteins can be expressed in E. coli and purified to homogeneity for functional studies [14, [16] [17] [18] [19] . Therefore in the present study, we aimed to amplify and clone RD1 ORFs in plasmid vectors, express them in E. coli and purify the mycobacterial proteins to homogeneity.
Materials and Methods

Plasmids and E. coli Strains
The following plasmids and E. coli strains were used: pPCRScript (Stratagene, La Jolla, Calif., USA) was used for cloning of mycobacterial DNA and the recombinant plasmids were propagated in XL1-Blue strain of E. coli (Stratagene). pGEX-4T-1 and pGEX-4T-2 vectors (Amersham-Pharmacia Biotech AB, Uppsala, Sweden) were used to clone mycobacterial genes for expression in BL-21 (Novagen, Madison, Wisc., USA) and XL-1 blue strains of E. coli . pET29a vector was used for cloning and expression of mycobacterial genes in BL-21-DE3 strain of E. coli (Novagen). DH5 ␣ strain of E. coli (Life Technologies, USA) was used to propagate all the parent plasmid vectors.
Isolation and Manipulation of M. tuberculosis Genomic DNA M. tuberculosis H37Rv was obtained from the American Type Culture Collection (Rockville, Md., USA), grown at 37 ° C in Middlebrook 7H9 medium (Difco, USA) and used for isolation of genomic DNA, as previously described [15] . The isolated genomic DNA served as the source for the amplification of RD1 genes by PCR. All DNA manipulations, restriction endonuclease digestion, sequencing and transformation were performed using standard procedures [20] .
Oligonucleotide Primers
The oligonucleotide primers to amplify full-length ORF10 to ORF15 genes were designed based on the nucleotide sequence of these ORFs in the M. tuberculosis genome, as described previously [15, 16] . As examples, the DNA sequences of forward (F) and reverse (R) primers for ORF11 and ORF12 are shown: -ORF11F: 5 -CGC GGA TCC ATG GCT GAA CCG TTG GCC GTC-3 ; -ORF11R: 5 -CCC AAG CTT TCA CAA CGT TGT GGT TGT TGA-3 ; -ORF12F: 5 -C GAG CTC GTG GGC AGC GTA GGC CCG GAA-3 ; -ORF12R: 5 -CCC AAG CTT TCA TTG GTC ACG GCG ACG CAT-3 . The F primers for ORF10, ORF11 and ORF14 had a Bam HI and ORF12, ORF13 and ORF15 had a Sac I restriction site incorporated at the 5 end (bold-face nucleotides) and an initiation codon (underlined). All of the R primers had a Hin dIII restriction site (bold-face nucleotides) at the 5 end and a termination codon (underlined).
PCR Amplification of Target DNA and Cloning in Plasmid Vectors
PCR procedures for amplification of ORF10 to ORF15 from the genomic DNA of M. tuberculosis were performed as described previously [15] . The DNA products were resolved by agarose gel electrophoresis, purified and ligated to pPCR-Script to transform E. coli cells using standard procedures [16] . To confirm the identity of the cloned DNA, restriction digestion analysis and DNA sequence analysis were performed according to standard procedures [15] .
For expression in E. coli , ORF10, ORF11 and ORF14 genes were subcloned from pPCR-Script into pGEX-4T-2 vector to be expressed as fusion proteins with glutathione S-transferase (GST) as the fusion partner at the N-terminus of the protein, using standard procedures [16] . ORF11 and 15 could not be cloned directly from pPCR-Script into pGEX vectors because the Bam HI site of ORF11 was not in frame with that of the vector, and the latter has no Sac I site suitable for cloning ORF15. The other restriction sites common for the two vectors were also present inside the ORFs. For these reasons, the two ORFs were digested from pPCR-Script with Bam HI, Hin dIII (ORF11) and Sac I, Hin dIII (ORF15) and ligated into pET29-a. From this vector, ORF11 and 15 were excised with Bam HI, Xho I and Eco RI, Xho I, respectively, and finally ligated to pGEX4T-1 vectors suitable for expression [16] . The recombinant plasmids were transformed into appropriate E. coli strains (BL-21-DE3, XL-1 blue and BL-21) for protein expression, as described previously [16] .
Induction, Identification and Purification of Recombinant Proteins
Recombinant proteins were expressed in E. coli cells using standard procedures [19] , and processed for detection of expressed proteins using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by staining of the gels with Coomassie blue [19] . The identity of the expressed proteins was further confirmed. Their stability in different E. coli strains was determined by Western immunoblotting using anti-GST antibodies [19] . The recombinant proteins purified from E. coli lysates upon loading onto glutathione-Sepharose columns and cleavage of the fusion proteins occurs upon reaction with thrombin protease, as described previously [19] . The GST-free recombinant proteins were further purified to remove other contaminating proteins by fast protein liquid chromatography (FPLC, Pharmacia, UK). Any endotoxins contaminating the recombinant proteins were removed by using prepacked endotoxin removing columns (Detoxi-Gel TM , Pierce, Rockford, Ill., USA) according to the manufacturer's instructions.
The amplification of ORF10 and ORF15 was achieved by using the reaction mixture described previously, but the amplification of ORF11 and ORF13 required addition of 4% formamide and 8% DMSO, respectively, and the amplification of ORF12 and ORF14 required addition of both 8% formamide and 8% DMSO [15] . The PCR-amplified ORFs were purified and ligated to the pPCRScript vector to transform the cells of XL-1 blue strain of E. coli . Plasmids isolated from transformed cells were digested with the appropriate restriction enzymes to confirm the presence of the inserts.
Results
Amplification of RD1 ORFs by PCR and Cloning in pPCR-Script
Five of the six ORFs, with the exception of ORF13, were successfully cloned in pPCR-Script. The identity of the cloned ORFs was confirmed by DNA sequencing.
Cloning and Expression of RD1 ORFs in Expression Vectors
ORF10 and ORF14 were directly subcloned from pPCR-Script into pGEX-4T-2 and the fusion proteins were expressed in BL-21 and XL-1 blue strains of E. coli , as described previously. However, ORF11 and ORF15 could not be subcloned into the pGEX-4T vectors directly from pPCR-Script because of incompatible restriction sites. These ORFs were first subcloned in pET29a followed by cloning in pGEX-4T-1 and the proteins were expressed in E. coli from both vectors, as detected by SDS-PAGE and Western immunoblotting ( fig. 1 , data shown for ORF11 in pGEX-4T-1). Although full-length ORF12 could be cloned in pGEX-4T-2 as well as in pET29a, the expected recombinant protein was not expressed in transformed E. coli cells, when detected by SDS-PAGE and Western immunoblotting. Therefore, ORF12 was digested arbitrarily into several overlapping fragments and attempts were made to express them individually. The largest fragment successfully expressed was 1.3 kb covering about 73% of the protein from N-terminus.
Confirmation of Expression and Stability of Recombinant Proteins Expressed in E. coli
To confirm the expression of recombinant proteins and study their stability, E. coli lysates were probed with anti-GST antibodies in Western immunoblotting using anti-GST antibodies. The results confirmed that all the five recombinant proteins were expressed but appeared to be degraded in both XL-1 blue and BL-21 strains of E. coli ( fig. 2 a, results shown for ORF11 only). The protein degradation was so extensive in case of ORF10 and the expressed fragment of ORF12 that the band corresponding to recombinant protein of expected size was hardly visible in the Western immunoblots, whereas the degradation products of various sizes were quite marked ( fig. 2 b, results shown for ORF12 only).
Purification of Recombinant Proteins
Attempts were made to purify the recombinant RD1 proteins, free of the E. coli components and the fusion partner by affinity chromatography and FPLC of those ORFs that showed a high level of expression and a low level of degradation as fusion proteins, i.e. ORF11, ORF14 and ORF15. The recombinant ORF11 and ORF14 fusion proteins were abundant in the soluble fraction of E. coli lysates, which were loaded on glutathione-Sepharose 4B columns for purification. Upon cleavage with thrombin protease, RD1 proteins corresponding to the molecular weights of ORF11 and ORF14 were eluted ( fig. 3 , data shown for ORF11). However, both of these proteins were contaminated with an E. coli cellular protein appearing at around 73 kDa ( fig. 3 , data shown for ORF11). The contaminating protein was successfully removed by FPLC to obtain highly homogeneous recombinant ORF11 and ORF14 proteins ( fig. 4 ). 3 . SDS-PAGE analysis of eluted ORF11 protein after cleavage of the GST-ORF11 fusion proteins with thrombin protease on an anti-GST affinity column. The recombinant GST-ORF11 proteins were cleaved from the GST fusion partner on an anti-GST column after treating with thrombin protease, as described in Materials and Methods. The eluted fractions were resolved on SDS-PAGE gels. Lane 1: Low-molecular-weight protein marker. Lane 2: The eluted ORF11 protein free of the GST fusion partner (35 kDa, arrow 2). However, an E. coli protein at 73 kDa (arrow 1) was also eluted in these fractions.
In case of ORF15, most of the fusion protein was present in the form of pellets and very little was found in the soluble fraction of E. coli lysates. The pellets were treated with several concentrations of urea (1, 2, 4 and 6 M urea) to dissolve the fusion protein. Although the fusion protein was optimally solubilized in 6 M urea , all efforts (dilution with phosphate-buffered saline and dialysis to remove urea) failed to facilitate its binding to the glutathione columns. Thus, the recombinant ORF15 protein could not be purified.
Discussion
In this work we have studied six ORFs of RD1 (ORF10 to ORF15) for amplification from genomic DNA of M. tuberculosis by PCR, cloning in plasmid vectors, expression in different E. coli strains and purification of the expressed M. tuberculosis proteins. Although all of the ORFs could be amplified by PCR using genomic DNA from M. tuberculosis H37Rv, the reaction conditions varied. ORF10 and ORF15 were amplified using standard protocols of PCR with an annealing temperature of 65 ° C [15] . However, nonspecific DNA fragments were amplified when using standard protocols with primers for ORF11, ORF12, and ORF14, and no products were obtained for ORF13. Nonspecific products or absence of any distinct product could be due to the high GC contents of these regions (ORF11 66.7%, ORF12 70.4%, ORF13 67.5% and ORF14 75.4%) [14] . The GC contents of ORF10 and ORF15 (60.4 and 61.8%, respectively) are slightly less [14] , and this could have made the amplification of these easier than the others. The annealing temperature was varied between 53 and 70 ° C in attempts to improve specificity, without success. Formamide and DMSO have been reported to improve the specificity and yield of PCR [21, 22] , and the use of these chemicals helped the amplification of specific products of ORF11, ORF12, ORF13 and ORF14 [15] . However, the use of these reagents remains empirical, and it is not known which parameters of the reaction are affected. For example, these reagents may affect primer-melting temperature (Tm), the catalytic activity of the enzyme, or template and product structure [21, 22] .
All targeted RD1 ORFs were cloned in pPCR-Script, except ORF13, which is a 2.2-kb fragment encoded on the complementary strand of the genomic DNA overlapping ORF12 and ORF14 [15] . The amplified ORF13 was tailed with poly-adenine (A) by adding Taq DNA polymerase at the last cycle of the PCR amplification reaction, with subsequent attempts to clone the product into pGEM-T easy vector which has thymidine at the 3 -terminal of both ends [18] . However, these trials were unsuccessful (data not shown). In addition, we tried to clone this ORF using other plasmid systems, such as the pZero system described to give zero background of nonrecombinant product [23] , but again the attempts were unsuccessful, and ORF13 was dropped from further work.
ORF10 and ORF15 were initially subcloned into pQE-30 vector to be expressed as proteins fused to a 6 ! histidine tag at the N-terminal [24] . However, the expression of these proteins could not be detected either by Coomassie blue staining or by Western immunoblotting using antihistidine antibodies. These observations confirm the previous reports that most of the target proteins of M. tuberculosis did not show any expression and only 22% were well expressed in E. coli when an N-terminal His-tag was used [25] . However, a fusion protein approach enhanced the percentage of well-expressed proteins to 63% [26] . Therefore, attempts were made to express ORF10 and ORF15 proteins in The pGEX-4T vectors that use GST gene fusion system to express foreign proteins fused to the relatively large and stable GST (29-kDa) protein.
The pGEX-4T vectors provide high level expression of the fused protein, which is induced chemically by isopropyl ␤ -D -thiogalactosidase [16] . Cleavage of the desired protein from GST is achieved using a site-specific thrombin protease whose recognition sequence is located immediately upstream from the multiple cloning site on the pGEX plasmids [16] . Proteins can then, theoretically, be purified from bacterial lysates by affinity chromatography [16] . ORF10 and ORF14 were successfully expressed as GST fusion proteins, although Western immunoblot using anti-GST antibodies showed extensive (in case of ORF10) to some (in case of ORF14) degradation [15] . Since ORF10 and ORF12 proteins were extensively degraded in E. coli , we proceeded with purification of the expressed proteins from ORF11, ORF14, and ORF15. Success was achieved with the proteins from ORF11 and ORF14. After cleavage from the GST fusion partner, the two proteins were seen at 30 and 35 kDa, respectively, on SDS-PAGE, whereas their predicted molecular weights are 27 and 21 kDa, based on the size of respective genes [14] . Both proteins have several short repetitive motifs containing proline residues at the C-terminal end, a feature shared among several antigenic mycobacterial proteins, including MTC28 and 36 kDa antigens [29, 30] . A characteristic feature of these proteins is that they migrate slowly in SDS-PAGE gels compared to their expected molecular weights [29, 30] . The discrepancies between the calculated and apparent molecular weights of these antigenic proteins can therefore probably be attributed to the rigidity and reduced mobility of the protein backbone due to the abundance of proline residues.
Conclusion
Genes for all six selected RD1 proteins were amplified, five of which were cloned in plasmid vectors for expression in E. coli . However, obtaining full-length proteins was successful for only two, i.e. ORF11 and ORF14, due to extensive degradation or nonbinding to affinity columns of other recombinant proteins. Another disadvantage of the E. coli expression system is the lack of posttranslational modifications, often observed with M. tuberculosis proteins expressed naturally. These observations limit the use of E. coli as a host to express and purify putative mycobacterial proteins for functional studies and support the argument that efficient mycobacterial expression systems should be developed to obtain large quantities of M. tuberculosis proteins for functional characterization.
